The apparent diffusion coefficient is strongly correlated with extracellular volume,a measure of myocardial fibrosis,and subclinical cardiomyopathy in patients with systemic lupus erythematosus

Abstract

Background

Extracellular volume (ECV) has been histologically validated as a non-invasive quantitative index of myocardial fibrosis that does not require the use of contrast, which is contraindicated in patients with renal insufficiency.

Purpose

To evaluate the correlation between the contrast-free apparent diffusion coefficient (ADC) and ECV, an index of fibrosis.

Material and Methods

Twenty-four patients with systemic lupus erythematosus (SLE), who were predominantly women (mean age = 36 ± 12 years) and 12 normal participants (mean age = 38 ± 10 years) underwent cardiac magnetic resonance (CMR) via 3.0 T MR with T1 mapping. Diffusion-weighted imaging (DWI) and late gadolinium-enhanced (LGE) imaging served as the reference standards with which CMR was compared. The mean ADC, native T1, and ECV were calculated for each patient, and the correlations among these parameters were analyzed.

Results

Both SLE LGE-positive (LGE+) and SLE LGE-negative (LGE–) participants had higher native T1 values, ECV, and ADC than normal controls (P < 0.05). SLE LGE+ participants exhibited a higher ECV (0.31 ± 0.02) and ADC (2.44 ± 0.32 × 10⁻³mm²/s) than SLE LGE– participants (p < 0.05); however, SLE LGE+ and SLE LGE– participants had similar native T1 values (1227 ± 48.81 ms versus 1174.70 ± 95.80 ms, respectively; P > 0.05). ADC values were positively correlated with increased ECV (R²= 0.62) and native T1 values (R²= 0.28) in all participants.

Conclusion

ADC measurements are a suitable alternative to ECV that may be used to assess and quantify myocardial fibrosis in patients with SLE.

Keywords

Systemic lupus erythematosus myocardial fibrosis diffusion-weighted imaging (DWI)native T1 extracellular volume (ECV)late gadolinium-enhanced imaging

Get full access to this article

View all access options for this article.

References

Doria

Iaccarino

Sarzi-Puttini

et al.

Cardiac involvement in systemic lupus erythematosus. Lupus 2005; 14: 683–686.

Bartels

Buhr

Goldberg

et al.

Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort. J Rheumatol 2014; 41: 680–687.

Pieretti

Roman

Devereux

et al.

Systemic lupus erythematosus predicts increased left ventricular mass. Circulation 2007; 116: 419–426.

Abdel-Aty

Siegle

Natusch

et al.

Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach. Lupus 2008; 17: 561–567.

Bruder

Schneider

Nothnagel

et al.

EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase. J Am Coll Cardiol 2009; 54: 1457–1466.

Rehwald

Fieno

Chen

et al.

Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 2002; 105: 224–229.

Iles

Pfluger

Phrommintikul

et al.

Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 2008; 52: 1574–1580.

Flett

Hayward

Ashworth

et al.

Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 2010; 122: 138–144.

De Meester de Ravenstein

Bouzin

Lazam

et al.

Histological validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T. J Cardiovasc Magn Reson 2015; 17: 48–48.

10.

Miller

Naish

Bishop

et al.

Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging 2013; 6: 373–383.

11.

Aus dem Siepen

Buss

Messroghli

et al.

T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging 2015; 16: 210–216.

12.

Chen

Yao

et al.

Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping. Int J Cardiovasc Imaging 2016; 32: 1289–1297.

13.

Pop

Ghugre

Ramanan

et al.

Quantification of fibrosis in infarcted swine hearts by ex vivo late gadolinium-enhancement and diffusion-weighted MRI methods. Phys Med Biol 2013; 58: 5009–5028.

14.

Abdullah

Drakos

Diakos

et al.

Characterization of diffuse fibrosis in the failing human heart via diffusion tensor imaging and quantitative histological validation. NMR Biomed 2014; 27: 1378–1386.

15.

Tseng

W-YI

Dou

Reese

et al.

Imaging myocardial fiber disarray and intramural strain hypokinesis in hypertrophic cardiomyopathy with MRI. J Magn Reson Imaging 2015; 23: 1–8.

16.

Hochberg

. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725–1725.

17.

Yee

Farewell

Isenberg

et al.

The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients. Rheumatology (Oxford) 2011; 50: 982–988.

18.

Schulz-Menger

Bluemke

Bremerich

et al.

Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson 2013; 15: 35–35.

19.

Nguyen

Fan

Xie

et al.

In vivo contrast free chronic myocardial infarction characterization using diffusion-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2014; 16: 68–68.

20.

McGill

Ismail

Nielles-Vallespin

et al.

Reproducibility of in-vivo diffusion tensor cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 2012; 14: 86–86.

21.

Puntmann

D'Cruz

Smith

et al.

Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging 2013; 6: 295–301.

22.

Nguyen

Fan

et al.

Contrast-free detection of myocardial fibrosis in hypertrophic cardiomyopathy patients with diffusion-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2015; 17: 107–107.

23.

Laissy

Gaxotte

Pasi

. Cardiac diffusion-weighted MR imaging in recent, subacute and chronic myocardial infarction: a pilot study. J Magn Reson Imaging 2013; 38: 1377–1387.

24.

Mekkaoui

Reese

Jackowski

et al.

Diffusion MRI in the heart. NMR Biomed 2017; 30(3).

25.

Rapacchi

Wen

Viallon

et al.

Low b-value diffusion-weighted cardiac magnetic resonance imaging: initial results in humans using an optimal time-window imaging approach. Invest Radiol 2011; 46: 751–758.